The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 10, 2022

Primary Completion Date

February 10, 2024

Study Completion Date

April 10, 2024

Conditions

Corneal PerforationExposure KeratitisInfectious Keratitis

Interventions

COMBINATION_PRODUCT

OmniLenz®

OmniLenz® applied for 1 week in all patients after development of corneal perforation

Trial Locations (1)

Farwaniya Hospital, Kuwait City

All Listed Sponsors

lead

Farwaniya Hospital

OTHER_GOV